Your browser doesn't support javascript.
loading
Pathogenic variants in SMARCA1 cause an X-linked neurodevelopmental disorder modulated by NURF complex composition.
Picketts, David; Mirzaa, Ghayda; Yan, Keqin; Relator, Raissa; Timpano, Sara; Yalcin, Binnaz; Collins, Stephan; Ziegler, Alban; Pao, Emily; Oyama, Nora; Brischoux-Boucher, Elise; Piard, Juliette; Monaghan, Kristin; Sacoto, Maria Guillen; Dobyns, William; Park, Kristen; Fernández-Mayoralas, Daniel; Fernández-Jaén, Alberto; Jayakar, Parul; Brusco, Alfredo; Antona, Vincenzo; Giorgio, Elisa; Kvarnung, Malin; Isidor, Bertrand; Conrad, Solène; Cogné, Benjamin; Deb, Wallid; Stuurman, K E; Sterbova, Katalin; Smal, Noor; Weckhuysen, Sarah; Oegema, Renske; Innes, Micheil; Latsko, Maeson; Ben-Omran, Tawfeg; Yeh, Rebecca; Kruer, Michael; Bakhtiari, Somayeh; Papavasiliou, Antigone; Moutton, Sébastien; Nambot, Sophie; Chanprasert, Sirisak; Paolucci, Sarah; Miller, Kait; Burton, Barbara; Kim, Katherine; O'Heir, Emily; Bruwer, Zandre; Donald, Kirsten; Kleefstra, Tjitske.
  • Picketts D; Ottawa Hospital Research Institute.
  • Mirzaa G; Seattle Children's Hospital.
  • Yan K; Ottawa Hospital Research Institute.
  • Relator R; London Health Sciences Centre.
  • Timpano S; Ottawa Hospital Research Institute.
  • Yalcin B; Inserm.
  • Collins S; INSERM UMR-S 1231, University of Bourgogne Franche-Comté.
  • Ziegler A; University Hospital of Angers.
  • Pao E; Seattle Children's Research Institute.
  • Oyama N; Seattle Children's Research Institute.
  • Brischoux-Boucher E; Université de Franche-Comté.
  • Piard J; CHU Besançon.
  • Monaghan K; GeneDx.
  • Sacoto MG; GeneDx, Gaithersburg, MD.
  • Dobyns W; University of Minnesota.
  • Park K; University of Colorado Denver School of Medicine.
  • Fernández-Mayoralas D; Hospital Universitario Quirónsalud.
  • Fernández-Jaén A; Department of Pediatrics and Neurology, Hospital Universitario Quirónsalud, School of Medicine, Universidad Europea de Madrid.
  • Jayakar P; Division of Genetics and Metabolism, Nicklaus Children's Hospital.
  • Brusco A; University of Turin.
  • Antona V; University of Palermo.
  • Giorgio E; University of Pavia.
  • Kvarnung M; Karolinska Institutet.
  • Isidor B; CHU de Nantes.
  • Conrad S; Nantes Université.
  • Cogné B; CHU Nantes.
  • Deb W; Nantes Université.
  • Stuurman KE; Department of Clinical Genetics, Erasmus University Medical Center.
  • Sterbova K; Charles University and Motol Hospital.
  • Smal N; VIB Center for Molecular Neurology.
  • Weckhuysen S; VIB Center for Molecular Neurology.
  • Oegema R; University Medical Center Utrecht.
  • Innes M; University of Calgary.
  • Latsko M; The Steve and Cindy Rasmussen Institute for Genomic Medicine.
  • Ben-Omran T; Hamad Medical Corporation.
  • Yeh R; Boston Children's Hospital.
  • Kruer M; Phoenix Children's Hospital.
  • Bakhtiari S; University of Arizona College of Medicine.
  • Papavasiliou A; IASO Children's Hospital.
  • Moutton S; CHU François Mitterrand.
  • Nambot S; Centre de Génétique et Centre de référence «Anomalies du Développement et Syndromes Malformatifs¼, Hôpital d'Enfants, Centre Hospitalier.
  • Chanprasert S; University of Washington.
  • Paolucci S; University of Washington.
  • Miller K; University of Washington School of Medicine.
  • Burton B; Northwestern University Feinberg School of Medicine.
  • Kim K; Northwestern University Feinberg School of Medicine.
  • O'Heir E; Broad Institute of MIT and Harvard.
  • Bruwer Z; University of Cape Town.
  • Donald K; Division of Developmental Paediatrics, Department of Paediatrics and Child Health, Red Cross War Memorial Children's Hospital, Klipfontein Road/Private Bag, Rondebosch, 7700/7701, Cape Town, South A.
  • Kleefstra T; Radboud University Medical Centre.
Res Sq ; 2023 Sep 29.
Article en En | MEDLINE | ID: mdl-37841849
ABSTRACT
Pathogenic variants in ATP-dependent chromatin remodeling proteins are a recurrent cause of neurodevelopmental disorders (NDDs). The NURF complex consists of BPTF and either the SNF2H (SMARCA5) or SNF2L (SMARCA1) ISWI-chromatin remodeling enzyme. Pathogenic variants in BPTF and SMARCA5 were previously implicated in NDDs. Here, we describe 40 individuals from 30 families with de novo or maternally inherited pathogenic variants in SMARCA1. This novel NDD was associated with mild to severe ID/DD, delayed or regressive speech development, and some recurrent facial dysmorphisms. Individuals carrying SMARCA1 loss-of-function variants exhibited a mild genome-wide DNA methylation profile and a high penetrance of macrocephaly. Genetic dissection of the NURF complex using Smarca1, Smarca5, and Bptfsingle and double mouse knockouts revealed the importance of NURF composition and dosage for proper forebrain development. Finally, we propose that genetic alterations affecting different NURF components result in a NDD with a broad clinical spectrum.
Palabras clave